ライフサイエンスコーパス: postsurgery

1 ry only, for 24 hr postsurgery, or for 72 hr postsurgery).

2 presented with a caged rattlesnake pre- and postsurgery.

3 fe and emotional functioning during the year postsurgery.

4 postoperative periods and at 8 and 26 weeks postsurgery.

5 W) were measured preoperatively and 8 months postsurgery.

6 cutaneously) and necropsied at 2 or 10 weeks postsurgery.

7 return of lesion-induced deficits by Week 5 postsurgery.

8 d lesions significantly disrupted PPI 1 week postsurgery.

9 the distal surface of tooth #8 at 15 months postsurgery.

10 e first phase of cell death peaked at 1 hour postsurgery.

11 e processing in male mice at 6, 24, and 72 h postsurgery.

12 al PGA-TMC could not be observed at 24 weeks postsurgery.

13 prior to surgery; and at 3, 6, and 9 months postsurgery.

14 erative protocol and were evaluated 6 months postsurgery.

15 as the global rating scale score for 2 weeks postsurgery.

16 ver 64 years and were followed for 18 months postsurgery.

17 ted, and all animals regained weight quickly postsurgery.

18 aphs were obtained at baseline and at 1-year postsurgery.

19 mm with CTG (96% root coverage), at 6 months postsurgery.

20 ses, it completely resolved within 12 months postsurgery.

21 ity of life, and complications up to 3 years postsurgery.

22 was observed at 1-5 min after PHx and 60 min postsurgery.

23 tive protocol and were evaluated at 6 months postsurgery.

24 prior to surgery, and at 6, 9, and 12 months postsurgery.

25 across TNM stages I to III and years 1 to 5 postsurgery.

26 in AMPA receptor subunit composition at 72 h postsurgery.

27 +/- 12.3 degrees, respectively, at 3 months postsurgery.

28 , this narrowing remained stable at 3 months postsurgery.

29 y guide the long-term management of patients postsurgery.

30 antly in both groups after 1, 2, and 3 years postsurgery.

31 dity, mortality, and quality of life 4 weeks postsurgery.

32 ative pain scores from end of surgery to 6 h postsurgery.

33 ower total and prescription costs by 3 years postsurgery.

34 mary outcome was physical fatigue at 1 month postsurgery.

35 lateral leg venography between 7 and 11 days postsurgery.

36 the urine albumin-creatinine ratio on day 7 postsurgery.

37 mptoms and quality of life (QOL) of pre- and postsurgery.

38 ttent intravenous paracetamol up to 48 hours postsurgery.

39 rity and neovascularization on days 7 and 28 postsurgery.

40 rogated, and OA was prevented up to 12 weeks postsurgery.

41 nee joints after ACLT, particularly on day 7 postsurgery.

42 salvage both in the short-term and at 1 year postsurgery.

43 X-II) levels were measured on days 35 and 70 postsurgery.

44 Animals were killed on day 70 postsurgery.

45 f bisphosphonate use on the risk of fracture postsurgery.

46 mug/ml; n = 14 rats) were performed on day 7 postsurgery.

47 histologic analysis after 70 days (10 weeks) postsurgery.

48 s 75% and five patients developed metastases postsurgery.

49 eline; at 1, 3, and 6 weeks; and at 6 months postsurgery.

50 100% recovery of the liver mass after 6-7 d postsurgery.

51 tochondrial complex I were evident on day 14 postsurgery.

52 ease: two stage 2A with gross residual tumor postsurgery, 11 stage 2B with ipsilateral or midline lym

53 Postsurgery, 13 patients had visible residual disease, a

54 ng 30.1% with acute coronary syndrome, 22.9% postsurgery, 13.3% respiratory failure, and 8.4% ventric

55 mL) was higher than OPN greater than 6 weeks postsurgery (177 ng/mL +/- 29 ng/mL; P = .003).

56 markedly improved corneal sensation 6 months postsurgery (3 eyes; mean [SD] central esthesiometry, 55

57 impacted postsurgery OPN: OPN < or = 6 weeks postsurgery (303 n/mL +/- 26 ng/mL) was higher than OPN

58 een in sham-operated animals at 1 and 3 days postsurgery (39.5% +/- 2.5 and 44% +/- 1.0, respectively

59 of 8.8+/-2.3 mm to 4.4+/-1.6 mm at 6 months postsurgery (4.4+/-1.5 mm gain), while PD was reduced fr

60 .1 mm presurgery to 3.3+/-1.1 mm at 6 months postsurgery (5.0+/-1.8 mm reduction).

61 Presurgery and postsurgery (6-month) data were compared using Student's

62 Among 552 patients admitted to the ward postsurgery, 68 (12.3%) developed at least one grade I t

63 ed groups showed changes in social dominance postsurgery, although changes in other measures varied b

64 25% increase in fracture risk at 2.5-5 years postsurgery among patients undergoing a THR.

65 and significantly less frequently with year postsurgery among the 995 respondents with assessable re

66 The case rate for CRF was 24% (n = 51) postsurgery and 31% (n = 69) at end of treatment; it bec

67 ationship between functional outcome 3 years postsurgery and 4 predictor domains: pain or complicatio

68 t in 78% of cases, the signature was reduced postsurgery and disappeared entirely in 33%.

69 Calvaria were harvested at 12 weeks postsurgery and evaluated histomorphometrically, by cont

70 otographs were taken between 8 and 12 months postsurgery and evaluated using a visual analog scale by

71 , and REC were remeasured at 6 and 12 months postsurgery and osseous measurements repeated at 12 mont

72 The animals were euthanized 4 weeks postsurgery and tissue blocks processed for histometric

73 At two months postsurgery and with a regimen of 200 mg of itraconazole

74 uprofen (800 mg 1 hour presurgery and 400 mg postsurgery) and one with a placebo.

75 rption, which was markedly increased 2 weeks postsurgery, and prevented the subsequent increase in bo

76 At 3 months postsurgery, animals were administered a selective PDE4B

77 hanges in symptom scores between the pre and postsurgery assessments were measured, and compared betw

78 , a narrow radiolucent gap formed by 1 month postsurgery at the initially tight visual interface betw

79 Twenty-eight days postsurgery, barbel axons had grown out several millimet

80 ke peptide 1 response were all predictors of postsurgery beta-cell function, although weight loss app

81 tive observational study to compare pre- and postsurgery changes in reflux symptoms between cholecyst

82 mal bleeding disorder, usually posttrauma or postsurgery, characterized by reduced levels of coagulat

83 TNM stage and year postsurgery clearly affect follow-up practice; this anal

84 ptide rose during hypoglycemia but rose less postsurgery compared with presurgery.

85 blems were significantly greater immediately postsurgery compared with retrospective reports before d

86 Postsurgery complications occurred in six patients (14%)

87 ral outcome was unrelated to pre-, peri-, or postsurgery complications.

88 ttie-Bresnahan locomotor scores at 1 and 3 d postsurgery confirmed early functional decline in all SC

89 without access to a running wheel (RW) from postsurgery day 0 to 6.

90 n timely biomarker analysis within a 2-month postsurgery delay.

91 Radiographs taken only 5 months postsurgery demonstrated advanced bone loss apical to th

92 iabetes and no venous edema with ulcerations postsurgery (either no history or remission); and presur

93 who underwent phacoemulsification and had a postsurgery follow-up of 6 months were included.

94 Patients 5 years postsurgery for breast cancer appear to have a very slow

95 raphs were exposed at baseline and 12 months postsurgery for computer assisted densitometric image an

96 Animals were euthanized at 8 and 24 weeks postsurgery for histologic observations.

97 The animals were euthanized at 12 weeks postsurgery for histometric analysis.

98 al attachment (2.59 mm) were obtained 1 year postsurgery for the GTR sites.

99 e association between bisphosphonate use and postsurgery fracture risk.

100 Early-regenerating axons (10 days postsurgery), having no or few myelin layers, were disor

101 symptoms were associated with presurgery-to-postsurgery improvements in multiple outcomes at years 1

102 mes were clinically meaningful presurgery to postsurgery improvements in pain and function using scor

103 d GLP-1 concentrations were assessed 30 days postsurgery in GIBP and sham pair-fed (sham.PF) groups.

104 reported cognitive decline observed at 72 h postsurgery in mice might be the consequence of temporal

105 xamined whether short-term changes (</=0.5 y postsurgery) in energy intake and macronutrient composit

106 bsequent increase in bone formation 10 weeks postsurgery, in the untreated tibial plateau of ACLT joi

107 ed a variety of neuropathic symptoms 2 weeks postsurgery, including mechanical and cold allodynia, an

108 /- 10.7, and 29.7 +/- 8.1 degrees at 1 month postsurgery, indicating angle narrowing of 34%-42%, and

109 poly(lactideco-glycolide) for prevention of postsurgery-induced abdominal adhesions.

110 n hazard of recurrence between years 5 to 12 postsurgery is 4.3% per year.

111 the latter cohort were compared with matched postsurgery levels.

112 Seven days postsurgery, LTF was studied in anaesthetized, neuromusc

113 ts was 3.35 mm (SD +/- 0.49) and at 6 months postsurgery, mean recession was 0.47 mm (SD +/0.62).

114 he Student paired t-test to compare pre- and postsurgery measurements.

115 ind utility in therapeutic planning to avoid postsurgery metastatic acceleration.

116 Seven to nine days postsurgery, mice were euthanized, the urinary bladder r

117 espiratory fitness and age in the context of postsurgery mortality and morbidity in older people.

118 Postsurgery mortality and morbidity increase with age.

119 currence of seizures with impaired awareness postsurgery: MRI findings (eg, HR adjusted for other var

120 OPN at recurrence was elevated from postsurgery nadir.

121 f tumor-node-metastasis (TNM) stage and year postsurgery on practice patterns.

122 Postsurgery OPN (256 ng/mL +/- 21 ng/mL) measured at mea

123 to presurgery OPN and use of thoracotomy to postsurgery OPN.

124 Time from surgery significantly impacted postsurgery OPN: OPN < or = 6 weeks postsurgery (303 n/m

125 outcome assessors were blinded until 7 days postsurgery or discharge if earlier.

126 and negative perception of 1-year prognosis postsurgery (OR, 0.27; 95% CI, 0.14-0.50; absolute risk,

127 (preinjury only, postinjury only, for 24 hr postsurgery, or for 72 hr postsurgery).

128 ative to the nonsurgical cohort after 1 year postsurgery (P < 0.001).

129 failed to vary between 1 month and 3 months postsurgery (P = .481).

130 Postsurgery pathologic findings and R0 resection were co

131 , or baseline N stage) predicted the type of postsurgery pathologic response, OS, or DFS.

132 t is not known whether metastatic disease in postsurgery patients inhibits this recovery.

133 ned significantly low in the 13- to 24-month postsurgery period (aORs, 0.77 [95% CI, .68-.86] and 0.7

134 5]) and remained high in the 13- to 24-month postsurgery period (aORs, 1.29 [95% CI, 1.09-1.54] and 1

135 sit or hospitalization in the 0- to 12-month postsurgery period decreased significantly for SSTI (aOR

136 ncreased significantly in the 0- to 12-month postsurgery period for intra-abdominal infection (aOR, 2

137 and return to work (P = .04) over the 6-week postsurgery period, as compared with laparotomy patients

138 At baseline and at 6 months postsurgery, probing depth and clinical attachment level

139 Postsurgery PRP shows improved cataract surgery results

140 e identified as predictors of TIA at 1 month postsurgery (R(2) = .907).

141 vaccine platform may be valuable in reducing postsurgery recurrence in a variety of epithelial neopla

142 There were also marked postsurgery reductions in levels of glucagon, cortisol,

143 no history or remission); and presurgery-to-postsurgery reductions in weight and depressive symptoms

144 oncentrations were determined 14 and 28 days postsurgery, reflecting rapid and sustained weight loss

145 mg/kg) in a within-subject design 2-3 weeks postsurgery revealed a normalization of PPI.

146 mouse metastatic mammary carcinoma 4T1 in a postsurgery setting, IFN-gamma-deficient mice were found

147 ies given at regular intervals beyond 1 year postsurgery should be tested in future studies, and prov

148 ery, with matched samples from 2 to 5 months postsurgery, showed that in 78% of cases, the signature

149 he present study was to compare at 12 months postsurgery sites treated with open flap debridement (OF

150 t risk factor for having major complications postsurgery [stage 3, odds ratio (OR) = 1.24 (95% CI, 1.

151 At 2 and 8 mo postsurgery, subjects consumed a test drink with 6 mg (5

152 risk factor predicting significantly shorter postsurgery survival (P = 0.03), controlling for the sig

153 hPR (P = .006), R0 resection (P < .001), and postsurgery T and N stages (P = .01 and P < .001, respec

154 EUS T plus N and postsurgery T plus N correlation showed significant down

155 over time, they were still greater at 1 year postsurgery than before diagnosis.

156 m nonoperated controls and from animals 24 h postsurgery that were administered either NK-1RA or sali

157 Similarly, at 24 h postsurgery the mRNA expression of structural proteins (

158 At 6 and 12 wk postsurgery, the hind limb had significantly less bone m

159 Postsurgery, the mice were injected with vehicle or FGF2

160 At various times postsurgery, the opioid receptor antagonists naloxone or

161 Seven months postsurgery, the patient experienced no further hemorrha

162 At 9 months postsurgery, the patient is on full enteral nutrition an

163 s (two immediate; two late, at several years postsurgery); this occurred in only one bilateral patien

164 At 8 and 14 wk postsurgery, tibiae were significantly shorter than cont

165 ected in the SCAP hydrogel group at the 6-wk postsurgery time point.

166 ed intraperitoneally between 32 and 40 weeks postsurgery to treatment animals.

167 In both groups postsurgery, tracer-derived appearance of oral glucose w

168 ient age, tumor size, neurologic status, and postsurgery treatment, and were compared with survival a

169 s were taken at baseline and 12 to 15 months postsurgery using a Rinn alignment system.

170 m on the second scan when comparing pre- and postsurgery values for each patient.

171 In agreement with our prediction, postsurgery, VLPFC lesioned animals were impaired in per

172 dian) global rating scale scores for 2 weeks postsurgery were 76.9 (80) for LAC vs 74.4 (75) for open

173 R); and mineralization at 3, 6, and 12 weeks postsurgery were measured using densitometry, histomorph

174 apillary fine structure were observed 3 days postsurgery, when limb use was limited.

175 the 5 years before THR, but had higher rates postsurgery, which peaked at years 2.5-5 (adjusted RR 1.

176 isk in the cohort of patients presurgery and postsurgery, with the presurgery groups serving as the r